Letter by Westerink and Visseren Regarding Article, "Ezetimibe in Combination With Statins Ameliorates Endothelial Dysfunction in Coronary Arteries After Stenting: The CuVIC Trial (Effect of Cholesterol Absorption Inhibitor Usage on Target Vessel Dysfunction After Coronary Stenting), a Multicenter Randomized Controlled Trial"

Arterioscler Thromb Vasc Biol. 2017 May;37(5):e53. doi: 10.1161/ATVBAHA.117.309295.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anticholesteremic Agents*
  • Cholesterol
  • Coronary Vessels
  • Ezetimibe
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors*

Substances

  • Anticholesteremic Agents
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Cholesterol
  • Ezetimibe